Mistletoe treatment induces GM-CSF- and IL-5 production by PBMC and increases blood granulocyte- and eosinophil counts: a placebo controlled randomized study in healthy subjects.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  European Journal of Medical Research

• Publication date

  2005-10-18

• Fields of study

  Medicine, Environmental Science

• Identifiers
  PMID 16287602
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Influence of postoperative complementary treatment with lectin-standardized mistletoe extract on breast cancer patients. A controlled epidemiological multicentric retrolective cohort study.

  2003cited by this paper
• Methods for the in vitro determination of an individual disposition towards TH1‐ or TH2‐reactivity by the application of appropriate stimulatory antigens

  2003cited by this paper
• Comparison of Low-Dose versus Standard-Dose Colony Stimulating Factor in Patients with Chemotherapy-Induced Febrile Neutropenia

  2003cited by this paper
• Mistletoe in cancer - a systematic review on controlled clinical trials.

  2003cited by this paper
• Effects of a Lectin- and a Viscotoxin-Rich Mistletoe Preparation on Clinical and Hematologic Parameters: A Placebo-Controlled Evaluation in Healthy Subjects

  2002cited by this paper
• Cancer immunotherapy with interleukin 12 and granulocyte-macrophage colony-stimulating factor-encapsulated microspheres: coinduction of innate and adaptive antitumor immunity and cure of disseminated disease.

  2002cited by this paper
• Stimulation of the maturation of dendritic cells in vitro by a fermented mistletoe extract.

  2002cited by this paper
• Influence of pathological tumour variables on long-term survival in resectable gastric cancer

  2002cited by this paper
• In vivo-induction of antibodies to mistletoe lectin-1 and viscotoxin by exposure to aqueous mistletoe extracts: a randomised double-blinded placebo controlled phase I study in healthy individuals.

  2002cited by this paper
• GM‐CSF‐based cancer vaccines

  2002cited by this paper
• INTRACELLULAR SIGNAL TRANSDUCTION IN EOSINOPHILS AND ITS CLINICAL SIGNIFICANCE

  2002cited by this paper
• Therapeutic use of granulocyte and granulocyte-macrophage colony-stimulating factors in febrile neutropenic cancer patients

  2002cited by this paper
• Cytokines as a link between innate and adaptive antitumor immunity.

  2002cited by this paper
• Granulocyte macrophage colony-stimulating factor: current practice and novel approaches.

  2002cited by this paper
• Effects of a mistletoe preparation with defined lectin content on chronic hepatitis C: an individually controlled cohort study.

  2001cited by this paper
• Prognostic influence of tumor‐associated eosinophilic infiltrate in colorectal carcinoma

  2000cited by this paper
• Characterisation of immunological reactivity of patients with adverse effects during therapy with an aqueous mistletoe extract.

  1999cited by this paper
• Thionins from Viscum album L: influence of the viscotoxins on the activation of granulocytes.

  1999cited by this paper
• Toxicity of a standardized mistletoe extract in immunocompromised and healthy individuals.

  1999cited by this paper
• Modulation of the cellular and humoral immune responses of tumor patients by mistletoe therapy.

  1998cited by this paper
• Complementary Medicine in Cancer Patients: Demand, Patient’ Attitudes and Psychological Beliefs

  1998cited by this paper
• The expanding universe of T-cell subsets: Th1, Th2 and more.

  1996cited by this paper
• Th1 and Th2 in human diseases.

  1996cited by this paper
• TH 1 and TH 2 in Human Diseases

  1996cited by this paper
• Quantitative determination of lectins in mistletoe preparations.

  1995cited by this paper
• A plant lectin derived from Viscum album induces cytokine gene expression and protein production in cultures of human peripheral blood mononuclear cells.

  1995cited by this paper
• Comparative study on the cytotoxic effect of viscotoxin and mistletoe lectin on tumour cells in culture

  1995cited by this paper
• Mistletoe extract standardized for the galactoside-specific lectin (ML-1) induces beta-endorphin release and immunopotentiation in breast cancer patients.

  1994cited by this paper
• Interleukin-5, eosinophils, and disease.

  1992cited by this paper
• Interleukin-5, Eosinophils, and Disease

  1992cited by this paper
• Demonstration of specifically sensitized lymphocytes in patients treated with an aqueous mistletoe extract (Viscum album L.)

  1991cited by this paper
• Increased secretion of tumor necrosis factors alpha, interleukin 1, and interleukin 6 by human mononuclear cells exposed to beta-galactoside-specific lectin from clinically applied mistletoe extract.

  1990cited by this paper
• Modulatory potency of the beta-galactoside-specific lectin from mistletoe extract (Iscador) on the host defense system in vivo in rabbits and patients.

  1989cited by this paper
• The human hematopoietic colony-stimulating factors.

  1987cited by this paper
• Immunomodulatory effects of iscador: a Viscum album preparation.

  1986cited by this paper
• Geisteswissenschaft und Medizin

  1937cited by this paper

• Phytonutrient Profiles of Mistletoe and Their Values and Potential Applications in Ethnopharmacology and Nutraceuticals: A Review

  2025cites this paper
• Knochenmark-Boost bei Fatigue

  2025cites this paper
• Beyond Viscum album: Mistletoe Physiology and the pharmacological Potential of the Extensive Loranthaceae Family.

  2025cites this paper
• A Comprehensive Review on Phytochemical Profile, Traditional Uses, Pharmacology and Host-parasite Dynamics of Viscum album L.

  2024cites this paper
• Characterization of Viscum album L. Effect on Immune Escape Proteins PD-L1, PD-L2, and MHC-I in the Prostate, Colon, Lung, and Breast Cancer Cells

  2023cites this paper
• Cancer Metabolism as a Therapeutic Target and Review of Interventions

  2023cites this paper
• The Introspective Patient Experience of Mistletoe Therapy in Cancer: A Qualitative Study

  2023cites this paper
• Mistletoe lectin inhibits growth of Myc‐amplified small‐cell lung cancer

  2022cites this paper
• Mistletoe extracts for cancer treatment

  2022cites this paper
• Natural products derived from medicinal plants and microbes might act as a game-changer in breast cancer: a comprehensive review of preclinical and clinical studies

  2022cites this paper
• Investigation of adjuvant effect of viscum album and aesculus hippocastanum in FMD vaccines

  2021cites this paper
• Long-Term Survival of a Patient with Recurrent Dedifferentiated High-Grade Liposarcoma of the Retroperitoneum Under Adjuvant Treatment with Viscum album L. Extract: A Case Report

  2021cites this paper
• Viscum album L. homogenizer-assisted and ultrasound-assisted extracts as potential sources of bioactive compounds.

  2020cites this paper
• Biological activity of mistletoe: in vitro and in vivo studies and mechanisms of action

  2020cites this paper
• Mistletoe and Immunomodulation: Insights and Implications for Anticancer Therapies

  2019cites this paper
• Phytotherapie bei Rheuma

  2019cites this paper
• Ribosome-Inactivating Protein α-Momorcharin Derived from Edible Plant Momordica charantia Induces Inflammatory Responses by Activating the NF-kappaB and JNK Pathways

  2019cites this paper
• Quality of life in cancer patients treated with mistletoe: a systematic review and meta-analysis

  2019cites this paper
• Safety of intravenously applied mistletoe extract – results from a phase I dose escalation study in patients with advanced cancer

  2017cites this paper
• Viscum album neutralizes tumor-induced immunosuppression in a human in vitro cell model

  2017cites this paper
• Impact of Mistletoe Triterpene Acids on the Uptake of Mistletoe Lectin by Cultured Tumor Cells

  2016cites this paper
• Chemical Constituents of Viscum album L.: Implications for the Pharmaceutical Preparation of Mistletoe

  2015cites this paper
• Mistletoe Compounds as Anti-Cancer Drugs: Effects and Mechanisms in the Treatment of Glioblastoma

  2015cites this paper
• Integrative Medizin in der Pädiatrischen Onkologie: experimentelle und klinische Forschung

  2014cites this paper
• Triterpenoids Amplify Anti-Tumoral Effects of Mistletoe Extracts on Murine B16.F10 Melanoma In Vivo

  2013cites this paper
• Evidence-based Anticancer Materia Medica for Lymphoma

  2012cites this paper
• Quality of life, immunomodulation and safety of adjuvant mistletoe treatment in patients with gastric carcinoma – a randomized, controlled pilot study

  2012cites this paper
• Integrative oncology in the Middle East: from traditional herbal knowledge to contemporary cancer care.

  2012cites this paper
• A new development of triterpene acid‐containing extracts from Viscum album L. displays synergistic induction of apoptosis in acute lymphoblastic leukaemia

  2012cites this paper
• Integrative Medizin in der Pädiatrischen Onkologie - Experimentelle und klinische Forschung

  2012cites this paper
• European and Oriental mistletoe: From mythology to contemporary integrative cancer care

  2011cites this paper
• Safety and effects of two mistletoe preparations on production of Interleukin-6 and other immune parameters - a placebo controlled clinical trial in healthy subjects

  2011cites this paper
• Quality of life in breast cancer patients during chemotherapy and concurrent therapy with a mistletoe extract.

  2011cites this paper
• Herbs in hemato-oncological care: an evidence-based review of data on efficacy, safety, and drug interactions

  2010cites this paper
• Pharmacokinetics of natural mistletoe lectins after subcutaneous injection

  2010cites this paper
• Immunomodulatory Effects of Viscum album Extracts on Natural Killer Cells: Review of Clinical Trials

  2010cites this paper
• Mistletoe therapy in oncology.

  2008cites this paper
• Enhanced in vitro activation of immunocompetent cells in healthy individuals being subcutaneously 'vaccinated' with placebo (physiological saline).

  2008cites this paper
• Die Wirkung der Mistel bei degenerativen Erkrankungen des Bewegungsapparates – eine prospektive Falldokumentation

  2008cites this paper
• Mistletoe Preparation Iscador: Are there Methodological Concerns with Respect to Controlled Clinical Trials?

  2007cites this paper
• Suppressive Effect of a Standardized Mistletoe Extract on the Expression of Activatory NK Receptors and Function of Human NK Cells

  2007cites this paper
• Anti-asthmatic potential of a D-galactose-binding lectin from Synadenium carinatum latex.

  2007cites this paper
• Ethnopharmacology Approaches for Botanical Immunomodulators and Chemoprotectants in Cancer Therapy

  2007cites this paper
• In vitro immunoregulatory effects of Korean mistletoe lectin on functional activation of monocytic and macrophage-like cells.

  2007cites this paper
• Prolonged cytotoxic effect of aqueous extracts from dried viscum album on bladder cancer cells.

  2007cites this paper
• Ribosome-inactivating proteins: progress and problems

  2006cites this paper